SCHEMBL31661827

SCHEMBL31661827

O=C(O)CCCCC(=O)c1cc(Cl)ccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 2/20 0.58
FEN1 P39748 2/20 0.58
ALDH1A1 P00352 5/20 0.56
TP53 P04637 1/20 0.56
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
POLB P06746 1/20 0.46
OXER1 Q8TDS5 2/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5081080 1.00 ERCC5 (0.58) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL30808872 0.98 ERCC5 (0.57) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL27636539 0.98 ERCC5 (0.57) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL15619155 0.98 ERCC5 (0.57) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL31661713 0.89 ERCC5 (0.62) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL5081092 0.89 ERCC5 (0.62) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL8573471 0.86 ERCC5 (0.54) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL17746129 0.85 ERCC5 (0.53) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL11747784 0.84 ERCC5 (0.56) ERCC5FEN1ALDH1A1TP53LMNA
SCHEMBL13346899 0.84 ALDH1A1 (0.62) ERCC5FEN1ALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed